PMID: 19938684Nov 27, 2009Paper

Brain functional imaging of frontotemporal lobar degeneration

Brain and nerve = Shinkei kenkyū no shinpo
Seigo Nakano, Hiroshi Matsuda

Abstract

Frontotemporal lobar degeneration (FTLD) is one of the common diseases causing dementia by including degenerative changes within the brain. The clinical subtypes of FTLD comprise frontotemporal dementia (FTD), progressive nonfluent aphasia (PNFA), and semantic dementia (SD). In this review, the role of the brain functional imaging on diagnosing of FTLD is described. Regionally distinct patterns of hypoperfusion on single-photon emission computed tomography (SPECT) or hypometabolism on positron emission tomography (PET) are helpful in differentiation of FTLD, Alzheimer's disease (AD), dementia with Lewy bodies (DLB), and corticobasal degeneration (CBD). The recently developed techniques show great promise in detecting specific neuropathological changes in dementia such as amyloid and tau pathology.

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Aphasia

Aphasia affects the ability to process language, including formulation and comprehension of language and speech, as well as the ability to read or write. Here is the latest research on aphasia.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.